Analyst Susan Anderson from Canaccord Genuity initiated coverage on Nature's Sunshine Products with a Buy rating and a $18 price forecast. The company is expected to expand margins through digital investments, international growth, and innovation, aiming for a 15% adjusted EBITDA margin by FY28.